Kura Oncology Inc. (KURA)
NASDAQ: KURA
· Real-Time Price · USD
8.17
0.16 (2.00%)
At close: Sep 10, 2025, 3:59 PM
8.35
2.20%
After-hours: Sep 10, 2025, 07:44 PM EDT
Kura Oncology Revenue Breakdown
| Period Ending | Jun 30, 2025 |
|---|---|
| Operating Segments Revenue | 15.29M |
| Operating Segments Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 25.17M | 22.84M | 24.07M | 18.18M | 16.48M | 17.95M | 14.02M | 13.14M | 11.82M | 11.37M | 12.49M | 11.62M | 11.07M | 11.87M | 12.08M | 11.31M | 12.57M | 10.57M | 8.81M | 7.59M | 7.48M | 7.63M | 5.5M | 5.13M | 4.45M | 4.57M | 4.55M | 4.32M | 3.8M | 3.42M | 2.88M | 2.36M | 2.28M | 2.14M | 1.98M | 1.74M | 1.85M | 2.39M | 1.73M | 1.79M | 1.51M | 1.06M |
| Selling, General, and Administrative Revenue Growth | +10.22% | -5.13% | +32.41% | +10.34% | -8.22% | +28.08% | +6.62% | +11.20% | +3.93% | -8.92% | +7.46% | +4.93% | -6.69% | -1.76% | +6.83% | -10.05% | +18.93% | +20.03% | +16.00% | +1.57% | -1.95% | +38.66% | +7.11% | +15.34% | -2.58% | +0.42% | +5.30% | +13.71% | +10.95% | +19.09% | +22.02% | +3.47% | +6.45% | +8.35% | +13.38% | -6.09% | -22.42% | +38.29% | -3.57% | +19.06% | +42.08% | n/a |
| Research and Development Revenue | 62.78M | 55.97M | 52.27M | 41.7M | 39.73M | 36.27M | 32.53M | 29.33M | 28.18M | 25.19M | 22.67M | 24.97M | 24.26M | 20.91M | 20.96M | 22.37M | 21.07M | 20.32M | 17.52M | 16.6M | 13.7M | 12.57M | 13.46M | 12.54M | 11.44M | 10.38M | 12.08M | 11.66M | 11.48M | 11.57M | 8.12M | 7.14M | 5.65M | 5.51M | 5.5M | 5.32M | 4.94M | 4.65M | 5.11M | 4.63M | 4.4M | 3.63M |
| Research and Development Revenue Growth | +12.17% | +7.09% | +25.33% | +4.98% | +9.54% | +11.48% | +10.93% | +4.07% | +11.87% | +11.13% | -9.23% | +2.95% | +15.99% | -0.21% | -6.31% | +6.14% | +3.69% | +15.98% | +5.56% | +21.20% | +8.92% | -6.60% | +7.37% | +9.62% | +10.19% | -14.08% | +3.63% | +1.61% | -0.78% | +42.46% | +13.68% | +26.36% | +2.52% | +0.18% | +3.52% | +7.70% | +6.17% | -9.07% | +10.31% | +5.32% | +21.31% | n/a |